Stage 0 Melanoma (in situ)
…invasion of surrounding tissues, lymph nodes, or distant sites Stage melanoma in situ. Abnormal melanocytes are in the epidermis (outer…
Stage 0 Melanoma (in situ)
…invasion of surrounding tissues, lymph nodes, or distant sites Stage melanoma in situ. Abnormal melanocytes are in the epidermis (outer…
Subcutaneous Immunotherapies for Melanoma: What You Need to Know
…or III melanoma following complete resection (removal by surgery).1 Opdivo Qvantig is approved for adult patients with unresectable melanoma or…
Surgery
What Type of Surgery Is Performed to Remove Melanoma? Surgery is the first treatment step for the majority of melanomas,…
Talk to a Medical Expert
Do You Have Questions About Melanoma? AIM at Melanoma knows that a melanoma diagnosis can be confusing, but you don’t…
Int’l Melanoma Working Group
…melanoma therapies to market faster. AIM at Melanoma and the IMWG have set in motion the framework for the first…
Pediatric Melanoma
…patients younger than 20 years old in the United States. Pediatric melanoma can be divided into three main categories: conventional…
Follow Up By Stage
…leading cancer centers in the U.S. The NCCN panel for melanoma comprises key opinion leaders in melanoma from across the…
Tests After Diagnosis
What Happens After Being Diagnosed With Melanoma? The following information will help you understand what further tests might be ordered…
Understanding Your Diagnosis
What Happens After I’m Diagnosed With Melanoma? When you or someone you love is first diagnosed with melanoma, it may…
How Melanoma Is Staged
How is Melanoma Staged? Melanoma is staged using a system called TNM, created by the American Joint Committee on Cancer…
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026